DENVER, CO–UBQU, (Marketwired – Nov 1, 2016) – CEO of Ubiquitech Software Corp. (OTC PINK: UBQU), with pending symbol and name change to HempLife Today™, and the management of HempLife Today™ are announcing that it has completed a very successful BETA test of the previously announced (9.16.2016) Trial Offer of its popular CannazALL™ CBD GelCaps and will now start this campaign to the general public. This Trial Offer will differ slightly from the originally announced offer and cost just $9.95Read more
- CytoDyn Announces Productive Pre-BLA Meeting with FDA for PRO 140 Combination Therapy
- Maven to Launch Sports Network in Partnership with The Sports Xchange
- Freedom Leaf Enters $20 Billion Anti-Cholesterol Market With Acquisition of a Patent Pending Non-Prescription Formula. No FDA Approval Required. Complimentary Diversification In Health Care
- PotNetwork Holdings, Inc.’s Diamond CBD Continues Surpassing $2 Million In Sales Per Month Practically Doubling Revenues Year Over Year
- Chinese eSports Tournament Group Seeks to Add Cryptocurrency to Their Prize Pools
SMALL CAP MARKET NEWS
We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.
LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!
Stock Investors · Accredited Investors · Hedge Fund InvestorsLearn More